Skip to content

Effect of Active-Passive Trainer Cycling on Multiple Sclerosis

The Effect of Cycling Using Active-passive Trainers on Spasticity, Cardiovascular Fitness, Function and Quality of Life in People With Multiple Sclerosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02737904
Enrollment
24
Registered
2016-04-14
Start date
2016-08-01
Completion date
2017-07-31
Last updated
2017-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Muscle spasticity

Brief summary

This randomised controlled trial aims to explore the effectiveness of a four week programme of exercise using lower limb Active Passive trainer (APT) (MOTOmed trainer) in terms of spasticity in people with moderate to severe Multiple Sclerosis.

Detailed description

Exercise is beneficial for people with Multiple Sclerosis (pwMS). However, exercise options for those with moderate to high levels of disability are limited. Cycling, delivered with an Active Passive Trainer (APT) is one exercise option often offered within rehabilitation/exercise settings and many pwMS buy APTs for home use. Anecdotally, pwMS report they feel better and their spasticity reduces after APT cycling, however there is a lack of evidence to support this. 30 pwMS will be recruited from the Physical Disability Rehabilitation Unit at the Queen Elizabeth University Hospital, Glasgow, and randomised to APT + usual care or usual care only. Those in the APT group will receive 30 minutes of APT (2 mins passive warm up, 26 mins active cycling and 2 mins passive cool down), five days per week for 4 weeks. Outcome measures will be cardiovascular fitness measured using the oxygen uptake efficiency slope (OUES), spasticity assessed by Modified Ashworth Scale (MAS) and the Multiple Sclerosis Spasticity Scale (MSSS-88), function assessed by the Functional Independence Measure (FIM) and the Timed 25 foot walk test (T25FW), Quality of Life measured by MSQOL-54. Outcome measures will be assessed in both groups before and after the 4 week intervention period. Symmetry, distance cycled and power will be recorded following each cycling session in the intervention group.

Interventions

OTHERUsual care

Personalised in-patient rehabilitation programme

OTHERAPT

APT for 30 minutes per day on 5 days per week for 4 weeks: 2 minute warm up consisting of passive cycling, where the legs of the participant are moved passively by the APT at 10 revolutions per min (rpm). Next, the participant will cycle for up to 26 minutes, at 60rpm. In this phase, the participant is required to actively cycle and to maintain a symmetrical pattern of movement using the feedback on the display. If the participant is unable to actively cycle at any point during the 26 minute exercise period, or if they have a spasm, the MOTOmed APT will revert to the passive mode. The final phase is a cool down where participants again will have 2 minutes of passive cycling at 10rpm.

Sponsors

University of Glasgow
CollaboratorOTHER
NHS Greater Glasgow and Clyde
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* have a confirmed diagnosis of progressive MS * are aged over 18 years * have an Expanded Disability Status Scale (EDSS) of between 6.5 (requires two walking aids - pair of canes, crutches, etc - to walk about 20m without resting) and 8.5 (essentially restricted to bed much of day); has some effective use of arms (retains some self care functions) and spasticity in their lower limbs (self reported)

Exclusion criteria

* cognitive impairment (cannot understand instructions) * other co-morbidities which would preclude them taking part in exercise * visual impairment (such that they cannot see the screen on the APT)

Design outcomes

Primary

MeasureTime frameDescription
Effect of spasticity on daily life scored on Multiple Sclerosis Spasticity Scale (MSSS-88)Change from Baseline at 4 weeksScore on Multiple Sclerosis Spasticity Scale (MSSS-88)

Secondary

MeasureTime frameDescription
Cardiovascular fitness calculated using Oxygen Uptake Efficiency Slope (OUES)Change from Baseline at 4 weeksCalculated Oxygen Uptake Efficiency Slope (OUES)
Function - FIMChange from Baseline at 4 weeksScore on Functional Independence Measure (FIM)
Function - T25FWChange from Baseline at 4 weeksTimed 25-foot walk test (T25FW)
Spasticity scored on Modified Ashworth Scale (MAS)Change from Baseline at 4 weeksScore on Modified Ashworth Scale (MAS)
APT cycling performance - symmetryChange from Baseline at 4 weeksProportion of time when effort of right versus left leg is evenly distributed ie 50%/50%
APT cycling performance - distanceChange from Baseline at 4 weeksDistance cycled
APT cycling performance - powerChange from Baseline at 4 weeksOverall power (measured in watts)
Quality of Life (MSQOL)-54 scaleChange from Baseline at 4 weeksScore on Multiple Sclerosis Quality of Life (MSQOL)-54 scale

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026